Abstract
Enzymes are truly outstanding biological catalysts with the ability to accelerate the rate of chemical reactions up to 1019 times for specific substrates and reactions. New approaches based on amino acids or peptides as characteristic molecular moieties have led to a significant expansion of the field of artificial enzymes or enzyme mimics, catalyzing various reactions with rate increases up to 103. A number of possibilities now exist for the construction of artificial enzymes. These are generally synthetic polymers or oligomers with enzyme-like activities, often called synzymes. This review has basic information about Ideal Requirement for Artificial Enzymes Environment, Design Approach for Artificial Enzyme and their Significance for further development in this field.
Keywords: Artificial enzymes, synzyme, enzyme mimics, chemzymes, star polymers, catalysts, metalloproteins, peptides, de novo design, chirality
Current Enzyme Inhibition
Title: Artificial Enzymes: A Review
Volume: 7 Issue: 3
Author(s): Vandana Sharma and Mukesh Bachwani
Affiliation:
Keywords: Artificial enzymes, synzyme, enzyme mimics, chemzymes, star polymers, catalysts, metalloproteins, peptides, de novo design, chirality
Abstract: Enzymes are truly outstanding biological catalysts with the ability to accelerate the rate of chemical reactions up to 1019 times for specific substrates and reactions. New approaches based on amino acids or peptides as characteristic molecular moieties have led to a significant expansion of the field of artificial enzymes or enzyme mimics, catalyzing various reactions with rate increases up to 103. A number of possibilities now exist for the construction of artificial enzymes. These are generally synthetic polymers or oligomers with enzyme-like activities, often called synzymes. This review has basic information about Ideal Requirement for Artificial Enzymes Environment, Design Approach for Artificial Enzyme and their Significance for further development in this field.
Export Options
About this article
Cite this article as:
Sharma Vandana and Bachwani Mukesh, Artificial Enzymes: A Review, Current Enzyme Inhibition 2011; 7 (3) . https://dx.doi.org/10.2174/157340811798807623
DOI https://dx.doi.org/10.2174/157340811798807623 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Transforming Growth Factor-β in Cardiac Fibrosis
Current Enzyme Inhibition Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial [Hot Topic: Cardiac Cell Therapy: anno 2011 (Executive Guest Editor: Sophie Van Linthout)
Current Pharmaceutical Design Uptake and Metabolism of the Short-Chain Fatty Acid Butyrate, a Critical Review of the Literature
Current Drug Metabolism Role of Angiogenesis Inhibitors in Colorectal Cancer: Sensitive and Insensitive Tumors
Current Cancer Drug Targets MicroRNAs in Genetic Disease: Rethinking the Dosage
Current Gene Therapy Glycosidated Phospholipids – a Promising Group of Anti-Tumour Lipids
Anti-Cancer Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Cardiology Reviews Organoselenium Compounds in Cancer Chemoprevention
Mini-Reviews in Medicinal Chemistry Effects of PPARγ Ligands on Vascular Tone
Current Molecular Pharmacology Isothiocyanates as Cancer Chemopreventive Agents: Their Biological Activities and Metabolism in Rodents and Humans
Current Drug Metabolism Pharmacological Interactions on Blood Pressure Control in Arterial Hypertension, An Issue not to be Overlooked
Cardiovascular & Hematological Disorders-Drug Targets Antithrombotic Therapy in Cardiac Embolism
Current Cardiology Reviews Alstrom Syndrome: Genetics and Clinical Overview
Current Genomics Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
Endocrine, Metabolic & Immune Disorders - Drug Targets LPTS: A Novel Tumor Suppressor Gene and a Promising Drug Target for Cancer Intervention
Recent Patents on Anti-Cancer Drug Discovery Treatment of Hypertensive Complications in Pregnancy
Current Pharmaceutical Design Does Brachial Blood Pressure Need to Predict Cardiovascular Outcomes in End Stage Renal Disease? An Update
Current Hypertension Reviews A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets Disorders of Sex Development: A Review
Current Women`s Health Reviews